Trial Profile
A Prospective, Randomized, Multi-Center, Open-Label Pilot Study of Infuse Bone Graft With Mastergraft Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2024
Price :
$35
*
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Spinal disorders; Spondylolisthesis
- Focus Therapeutic Use
- Acronyms BONE
- Sponsors Medtronic
- 24 Jan 2024 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
- 24 Jan 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Apr 2026.
- 05 Dec 2022 Planned number of patients changed from 125 to 100.